HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jianguo Sun Selected Research
Jianguo Sun Research Topics
Disease
33
Neoplasms (Cancer)
05/2022 - 12/2007
20
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 12/2015
12
Lung Neoplasms (Lung Cancer)
01/2022 - 12/2007
7
Breast Neoplasms (Breast Cancer)
01/2021 - 01/2012
7
Hepatocellular Carcinoma (Hepatoma)
12/2017 - 04/2011
6
Glaucoma
12/2022 - 09/2016
5
Prostatic Neoplasms (Prostate Cancer)
12/2021 - 09/2011
5
Neoplasm Metastasis (Metastasis)
01/2019 - 09/2011
3
Carcinoma (Carcinomatosis)
07/2017 - 01/2012
2
COVID-19
09/2021 - 08/2021
2
Brain Neoplasms (Brain Tumor)
01/2021 - 01/2021
2
Pain (Aches)
01/2021 - 01/2021
2
Carcinogenesis
10/2020 - 01/2015
2
Disease Progression
01/2019 - 04/2016
2
Type 2 Diabetes Mellitus (MODY)
12/2017 - 12/2015
2
Blindness (Hysterical Blindness)
10/2017 - 05/2015
2
Cicatrix (Scar)
08/2017 - 01/2017
2
Phlebitis
08/2016 - 04/2016
2
Leukemia
08/2016 - 07/2013
2
Lymphatic Metastasis
03/2016 - 04/2013
2
Reperfusion Injury
01/2016 - 03/2014
2
Osteoporosis
10/2013 - 01/2013
2
Glioma (Gliomas)
10/2013 - 10/2012
1
Radiation Pneumonitis
03/2022
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2022
1
Adenocarcinoma of Lung
02/2022
1
Uveitis
01/2022
1
Wounds and Injuries (Trauma)
01/2022
1
Ganglion Cysts (Ganglion)
01/2022
1
Nasopharyngeal Carcinoma
10/2021
1
Stomatitis
10/2021
1
Inflammation (Inflammations)
09/2021
1
Corneal Neovascularization
09/2021
Drug/Important Bio-Agent (IBA)
11
Pharmaceutical Preparations
IBA
02/2021 - 01/2012
8
Tyrosine Kinase Inhibitors
IBA
02/2022 - 05/2016
7
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2013
6
ErbB Receptors (EGF Receptor)
IBA
02/2022 - 05/2016
6
Immune Checkpoint Inhibitors
IBA
09/2021 - 01/2018
6
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2012
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2021 - 09/2011
4
Cyclosporine (Ciclosporin)
FDA Link
Generic
09/2021 - 09/2016
4
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2021 - 05/2016
4
Gefitinib (Iressa)
FDA Link
12/2019 - 05/2016
3
proxalutamide
IBA
12/2021 - 10/2020
3
Arachidonic Acid (Vitamin F)
IBA
01/2021 - 10/2013
3
Messenger RNA (mRNA)
IBA
01/2021 - 03/2017
3
MicroRNAs (MicroRNA)
IBA
10/2020 - 07/2013
3
Radiation-Sensitizing Agents
IBA
01/2018 - 10/2012
3
asulacrine
IBA
12/2016 - 04/2016
3
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2012 - 12/2007
2
Brimonidine Tartrate (Alphagan)
FDA Link
Generic
12/2022 - 03/2017
2
Endostatins
IBA
03/2022 - 02/2012
2
Platinum
IBA
02/2022 - 04/2016
2
Nerve Growth Factors (Neurotrophins)
IBA
01/2022 - 12/2017
2
Androgen Receptors (Androgen Receptor)
IBA
12/2021 - 10/2020
2
Silicon Dioxide (Silica)
FDA Link
Generic
09/2021 - 12/2018
2
pembrolizumab
IBA
01/2021 - 01/2019
2
Biological Products
IBA
10/2020 - 01/2019
2
Circulating Tumor DNA
IBA
05/2020 - 01/2019
2
B7-H1 Antigen
IBA
01/2020 - 01/2018
2
Solutions
IBA
12/2019 - 08/2017
2
Metformin (Glucophage)
FDA Link
Generic
12/2019 - 12/2015
2
Peptides (Polypeptides)
IBA
01/2019 - 09/2007
2
Cadherins (E-Cadherin)
IBA
01/2019 - 01/2019
2
Indicators and Reagents (Reagents)
IBA
01/2018 - 01/2018
2
Cisplatin (Platino)
FDA Link
Generic
12/2017 - 12/2007
2
Amsacrine (AMSA)
IBA
12/2016 - 08/2016
2
Acids
IBA
01/2016 - 01/2007
2
Plant Preparations (Preparation, Plant)
IBA
01/2016 - 08/2009
2
Neuroprotective Agents
IBA
03/2014 - 04/2012
2
CpG ODN107
IBA
10/2013 - 10/2012
2
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
01/2012 - 12/2010
1
Therapeutic Uses
IBA
12/2022
1
Silicone Elastomers (SE 30)
IBA
12/2022
1
Ophthalmic Solutions (Eye Drops)
IBA
12/2022
1
endostar protein
IBA
03/2022
1
icotinib
IBA
02/2022
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
02/2022
1
Retinaldehyde (Retinal)
IBA
01/2022
1
NLR Proteins
IBA
01/2022
1
Long Noncoding RNA
IBA
01/2022
1
Collagen
IBA
01/2022
1
Anaplastic Lymphoma Kinase
IBA
12/2021
1
Contrast Media
IBA
11/2021
1
Lipids
IBA
10/2021
1
Bevacizumab (Avastin)
FDA Link
09/2021
1
Tamoxifen
FDA Link
Generic
01/2021
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2021
1
Thymosin
IBA
01/2021
Therapy/Procedure
15
Radiotherapy
05/2022 - 10/2012
12
Therapeutics
01/2021 - 01/2012
8
Drug Therapy (Chemotherapy)
02/2022 - 12/2007
3
Immunotherapy
01/2021 - 05/2019
2
Filtering Surgery
08/2017 - 01/2017
1
Cell Transplantation
01/2022
1
Keratectomy
01/2022
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2021
1
Massage (Zone Therapy)
10/2021
1
Contraindications
09/2021
1
Critical Care (Surgical Intensive Care)
08/2021